Patents by Inventor Yumin Yang

Yumin Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11922679
    Abstract: An automatic seismic facies identification method based on combination of Self-Attention mechanism and U-shape network architecture, including: obtaining and preprocessing post-stack seismic data to construct a sample training and validation dataset; building an encoder through an overlapped patch merging module with down-sampling function and a self-attention transformer module with global modeling function; building a decoder through a patch expanding module with linear upsampling function, the self-attention transformer module, and a skip connection module with multilayer feature fusion function; building a seismic facies identification model using the encoder, the decoder, and a Hypercolumn module, where the seismic facies identification model includes a Hypercolumns-U-Segformer (HUSeg); and building a hybrid loss function; iteratively training the seismic facies identification model with a training and validation set; and inputting test data into a trained identification model to obtain seismic facies co
    Type: Grant
    Filed: May 22, 2023
    Date of Patent: March 5, 2024
    Assignee: Xi'an Jiaotong University
    Inventors: Zhiguo Wang, Yumin Chen, Yang Yang, Zhaoqi Gao, Zhen Li, Qiannan Wang, Jinghuai Gao
  • Patent number: 11142291
    Abstract: This invention provides a floating platform with canted columns, and a new method of mooring line makeup and installation method that can be used for the canted columns. In one embodiment, the platform includes 3 columns having upper ends projecting above water surface. The columns are canted or inclined inward from the corner of hull toward the top of column. The 3 columns converge at the top of column such that each column will lean against the other 2 columns. Each column connects to the other 2 columns. Horizontally disposed pontoons interconnect adjacent columns at the lower ends. The columns and pontoons form a closed structure hull to support a foundation structure directly above the top of column.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: October 12, 2021
    Assignee: ARGUS MARINE SOLUTIONS, LLC
    Inventors: Zhiyong Yang, Tingting Li, Nan Feng, Yumin Yang
  • Patent number: 11110202
    Abstract: A differential tissue-engineered nerve including motor-like nerves and sensory-like nerves. The motor-like nerve and the sensory-like nerve respectively includes a motor-like nerve outer tube and a motor-like nerve fiber in the outer tube as well as a sensory-like nerve outer tube and a sensory-like nerve fiber in the outer tube. Schwann cells and/or fibroblasts derived from motor nerves and sensory nerves are respectively contained in surfaces or pores of the motor-like and sensory-like nerve outer tubes. Transsynaptic signal molecules Neuroligin-1 and Neuroligin-2 are contained in surfaces or pores of the motor-like and sensory-like nerve fibers. Neuroligin-1 is selectively used to specifically promote synaptic remodeling of motor neurons, while Neuroligin-2 is selectively used to specifically promote synaptic remodeling of sensory neurons, so that repair efficiency of motor nerve cells and sensory nerve cells is improved.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: September 7, 2021
    Assignee: NANTONG UNIVERSITY
    Inventors: Xin Tang, Cheng Sun, Gang Chen, Xiaosong Gu, Yumin Yang, Fei Ding, Yanpei Gong, Qianru He, Hongkui Wang, Mi Shen
  • Publication number: 20210268149
    Abstract: A differential tissue-engineered nerve including motor-like nerves and sensory-like nerves. The motor-like nerve and the sensory-like nerve respectively includes a motor-like nerve outer tube and a motor-like nerve fiber in the outer tube as well as a sensory-like nerve outer tube and a sensory-like nerve fiber in the outer tube. Schwann cells and/or fibroblasts derived from motor nerves and sensory nerves are respectively contained in surfaces or pores of the motor-like and sensory-like nerve outer tubes. Transsynaptic signal molecules Neuroligin-1 and Neuroligin-2 are contained in surfaces or pores of the motor-like and sensory-like nerve fibers. Neuroligin-1 is selectively used to specifically promote synaptic remodeling of motor neurons, while Neuroligin-2 is selectively used to specifically promote synaptic remodeling of sensory neurons, so that repair efficiency of motor nerve cells and sensory nerve cells is improved.
    Type: Application
    Filed: September 11, 2019
    Publication date: September 2, 2021
    Inventors: Xin TANG, Cheng SUN, Gang CHEN, Xiaosong GU, Yumin YANG, Fei DING, Yanpei GONG, Qianru HE, Hongkui WANG, Mi SHEN
  • Publication number: 20200317306
    Abstract: This invention provides a floating platform with canted columns, and a new method of mooring line makeup and installation method that can be used for the canted columns. In one embodiment, the platform includes 3 columns having upper ends projecting above water surface. The columns are canted or inclined inward from the corner of hull toward the top of column. The 3 columns converge at the top of column such that each column will lean against the other 2 columns. Each column connects to the other 2 columns. Horizontally disposed pontoons interconnect adjacent columns at the lower ends. The columns and pontoons form a closed structure hull to support a foundation structure directly above the top of column.
    Type: Application
    Filed: June 19, 2020
    Publication date: October 8, 2020
    Inventors: Zhiyong YANG, Tingting LI, Nan FENG, Yumin YANG
  • Patent number: 10766578
    Abstract: We have invented a floating platform with 3 canted columns, a new type of fairlead, and a new method of mooring line makeup and installation method, that can be used for canted columns. The platform includes 3 columns having upper ends projecting above water surface. The columns are canted or inclined inward from the corner of hull toward the central vertical axis. The 3 columns converge at the top of column such that each column will lean against the other 2 columns. Each column has two connection points to the other 2 columns. Horizontally disposed pontoons interconnect adjacent columns at the lower ends. The columns and pontoons form a closed structure hull to support a foundation structure directly above the top of column.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: September 8, 2020
    Assignee: Argus Marine Solutions, LLC
    Inventors: Tingting Li, Nan Feng, Yumin Yang
  • Publication number: 20200216148
    Abstract: We have invented a floating platform with 3 canted columns, a new type of fairlead, and a new method of mooring line makeup and installation method, that can be used for canted columns. The platform includes 3 columns having upper ends projecting above water surface. The columns are canted or inclined inward from the corner of hull toward the central vertical axis. The 3 columns converge at the top of column such that each column will lean against the other 2 columns. Each column has two connection points to the other 2 columns. Horizontally disposed pontoons interconnect adjacent columns at the lower ends. The columns and pontoons form a closed structure hull to support a foundation structure directly above the top of column.
    Type: Application
    Filed: January 8, 2019
    Publication date: July 9, 2020
    Applicant: Argus Marine Solutions, LLC
    Inventors: Tingting Li, Nan Feng, Yumin Yang
  • Patent number: 10639399
    Abstract: Provided is a use of one or more MicroRNA genes selected from miRNAs of Family Let-7, miR-21 or miR-222 in the construction of tissue engineered nerves and in the repair of peripheral nerve defects. An outer and/or internal surface or pores of a tissue engineered nerve graft are coated or adsorbed with polymeric nanomicrospheres carrying a Let-7 family miRNA inhibitor, miR-21, or miR-222, or a mimetic thereof, wherein the polymeric material is composed of biocompatible fibronectin and heparin. The regeneration of peripheral nerves and the construction of tissue engineered nerves are promoted by regulating the expression of MicroRNA genes which can effectively promote the proliferation of primary Schwann cells cultured in vitro and have an anti-apoptotic effect on neuronal cells. In-vivo test proves that bridging of the tissue engineered nerve graft can facilitate the regeneration of peripheral nerves, thus being useful in the treatment of peripheral nerve injury.
    Type: Grant
    Filed: April 5, 2017
    Date of Patent: May 5, 2020
    Assignee: NANTONG UNIVERSITY
    Inventors: Xiaosong Gu, Fei Ding, Xin Tang, Yumin Yang, Bin Yu, Shiying Li, Songlin Zhou, Luzhong Zhang, Yaxian Wang, Yun Gu, Hualin Sun
  • Publication number: 20190111179
    Abstract: Provided is a use of one or more MicroRNA genes selected from miRNAs of Family Let-7, miR-21 or miR-222 in the construction of tissue engineered nerves and in the repair of peripheral nerve defects. An outer and/or internal surface or pores of a tissue engineered nerve graft are coated or adsorbed with polymeric nanomicrospheres carrying a Let-7 family miRNA inhibitor, miR-21, or miR-222, or a mimetic thereof, wherein the polymeric material is composed of biocompatible fibronectin and heparin. The regeneration of peripheral nerves and the construction of tissue engineered nerves are promoted by regulating the expression of MicroRNA genes which can effectively promote the proliferation of primary Schwann cells cultured in vitro and have an anti-apoptotic effect on neuronal cells. In-vivo test proves that bridging of the tissue engineered nerve graft can facilitate the regeneration of peripheral nerves, thus being useful in the treatment of peripheral nerve injury.
    Type: Application
    Filed: April 5, 2017
    Publication date: April 18, 2019
    Inventors: Xiaosong GU, Fei DING, Xin TANG, Yumin YANG, Bin YU, Shiying LI, Songlin ZHOU, Luzhong ZHANG, Yaxian WANG, Yun GU, Hualin SUN
  • Patent number: 9492589
    Abstract: A tissue engineered nerve graft for repairing peripheral nerve injury consists of a nerve conduit and a extracellular matrix (ECM) that is secreted by autologous or allogeneic support cells and obtained by decellularization. A preparation method of the ECM-modified tissue engineered nerve grafts containing support cells, nerve conduit and constructing a ECM-modified tissue engineered nerve graft.
    Type: Grant
    Filed: May 27, 2013
    Date of Patent: November 15, 2016
    Assignee: NANTONG UNIVERSITY
    Inventors: Xiaosong Gu, Fei Ding, Yun Gu, Chengbin Xue, Yumin Yang, Yongjun Wang, Leilei Gong
  • Publication number: 20150352255
    Abstract: A tissue engineered nerve graft for repairing peripheral nerve injury consists of a nerve conduit and a extracellular matrix (ECM) that is secreted by autologous or allogeneic support cells and obtained by decellularization. A preparation method of the ECM-modified tissue engineered nerve grafts containing support cells, nerve conduit and constructing a ECM-modified tissue engineered nerve graft.
    Type: Application
    Filed: May 27, 2013
    Publication date: December 10, 2015
    Inventors: XIAOSONG GU, FEI DING, YUN GU, CHENGBIN XUE, YUMIN YANG, YONGJUN WANG, LEILEI GONG
  • Publication number: 20110270411
    Abstract: The present invention discloses an artificial nerve graft prepared by electrostatic spinning, the preparing method and a special apparatus used therefor. Said artificial nerve graft is in the shape of a tube composed of nano-fiber that is prepared by electrostatic spinning of a polymer. The materials used in the present invention are bio-degradable materials and of desirable biocompatibility with human body. The product of the present invention is free of exogenous toxic substances or substances having side effects. Furthermore, the tube wall is of a 3-dimensional structure having micropores contained therein thereby providing a path for supplying nutritions required for the growth of nerve cells. Another advantage of the present invention is that necessary induction and space are provided for the growth of the nerve cells.
    Type: Application
    Filed: March 31, 2010
    Publication date: November 3, 2011
    Inventors: Yumin Yang, Xiaosong Gu, Fei Ding, Shanqing Xu, Xiaoli Yan
  • Publication number: 20080249639
    Abstract: A medical artificial nerve graft containing silk fibroin used in bridging of nerve damage and its preparation method. The medical artificial nerve graft comprised of vessel or comprised of vessel and fibre scaffold, wherein at least one of the vessel and the fibre scaffold contains component of silk fibroin, and the wall of the vessel has three-dimensional structure provided with numerous microaptures. The preparation method includes the following steps: silk is used to prepare silk fibre; the silk fibroin fibre is used to prepare the vessel or the fibre scaffold containing silk fibroin; and combining the fibre scaffold with the vessel i.e. inlaying the fibre scaffold into the vessel and so on.
    Type: Application
    Filed: December 31, 2005
    Publication date: October 9, 2008
    Inventors: Xiaosong Gu, Yumin Yang, Fei Ding, Peiyun Zhang, Yan Liu, Mei Liu, Xuemei Chen, Xiaodong Wang